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1. Introduction
  Leptospirosis is caused by the pathogenic spirochaete 
belonging to the genus Leptospira, family Leptospiraceae, 
and order Spirochaetales. The reservoirs of Leptospira are 
rodents, which are the most common source of human 
infections worldwide[1]. Leptospirosis is predominantly 
recognized as an occupational disease, it is now 
increasingly seen as a disease of water recreational sport[1]. 
Leptospira after entering the human body through abrasions 
produces leptospiremia affecting all systems. The disease 
is often self-limiting and nonfatal, despite the possibility of 
the severe form, Weil’s disease[1]. In this report, we are able 
to identify two uncommon manifestations of leptospirosis, 
in a patient, namely Sweet’s syndrome and central nervous 
system vasculitis.
2. Case report
  An apparently healthy 45 year old woman with no co-
morbid diseases, working as a farmer, presented with a 
3 day history of fever and myalgias and a one day history 
of left sided hemiparesis and reddish skin lesions. On 
examination, she had tenderness of thigh muscles and had 
features of meningism. On examination of skin lesions, 
revealed multiple discrete erythematous papules and 
plaques (with central umbilication) over the face and limbs. 
Her neurological examination revealed left hemiparesis 
with upper motor neuron type of facial nerve palsy.
  Investigations showed total leukocyte count of 15 500 cells 
(with 84% neutrophils), erythrocyte sedimentation rate (ESR) 
of 55 mm/hr, C-reactive protein (CRP)-44.8 & creatinine 
kinase (CPK)-1 790 IU/dL. Urine examination showed 
proteinuria and granular casts. Neuro-imaging of the brain 
done by CT scan, MRI & MRA was normal. CSF studies 
revealed 8 lymphocytes and protein was 65 mg/dL. Urine 
dark ground microscopy showed motile spirochetes and a 
positive serum IgM for Leptospira[2]. 
  Since the patient being from an endemic area, being 
a farmer, and as she fulfilled the modified Faine’s criteria[3] 
for diagnosis, possibility of leptospirosis with central 
nervous vasculitis was considered. She was treated with 
crystalline penicillin and steroids, with complete recovery 
of neurological deficits in 36 hours and regression of skin 
lesions over a week. 
  A biopsy of the skin lesion was performed. Histopathology 
from biopsy (Figure 1 & 2) of the skin lesions was 
suggestive of Sweet’s syndrome (Acute febrile neutrophilic 
dermatosis). The skin biopsy was charecterised by 
hyperkeratosis and acanthosis of epidermis, neutrophilic 
infiltration and leukocytoclasis in lower dermis.
  To rule out other associations of Sweet’s syndrome, 
antinuclear antibody (ANA), LE cells, C-anti-neutrophil 
cytoplasmic antibody (c-ANCA), venereal disease research 
laboratory (VDRL), HIV, and Mantoux tests were performed 
and all were negative on testing.
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Figure 1. Histopathology (100伊) showing (I) hyperkeratosis of 
epidermis (II) neutrophilic infiltration in the lower dermis.
 
Figure 2.  Histopathology (450 伊) showing (I) thickening stratum 
spinosum (II) dermis with neutrophils and leukocytoclasia with no 
evidence of vasculitis.
3. Discussion
  The Leptospira enter the human body through mucous 
membranes or abraded skin which come in contact with 
contaminated water from environmental sources. After its 
entry through skin or mucosa the Leptospira multiply in 
the blood stream and also in various tissues. The resulting 
leptospiremia affects all systems, particularly the liver and 
kidney. The disease is most often self-limited and nonfatal, 
despite the possibility of severe complications involving 
various systems[1]. 
  Diagnosis of leptospirosis is by identifying motile 
spirochaetes in urine by dark ground microscopy or by 
detecting Ig-M against Leptospira[2]. The more definitive 
tests for leptospirosis is by PCR, culture of blood or urine, 
and or a positive microscopic agglutination test[2]. This 
patient had positive urine microscopy and by IgM for 
Leptospira and also fulfilled the modified Faine’s criteria for 
the diagnosis of leptospirosis[3].
  The skin lesions found in this patient were multiple 
discrete erythematous papules and plaques distributed 
predominantly on the face and limbs, which were tender 
on palpation. To ascertain the pathology a skin biopsy was 
done. The histopathologic features of skin biopsy were 
typical of Sweet’s syndrome[4].
  Sweet’s syndrome is otherwise known as acute febrile 
neutrophilic dermatosis. Sweet’s syndrome is characterized 
by the clinical symptoms of fever, neutrophilia, tender 
erythematous skin lesions. The skin lesions may be localized 
or generalised. The lesions vary from papules and nodules to 
plaques. Sweet’s syndrome is seen in three forms: the classical 
(or idiopathic), malignancy-associated, and drug-induced[5]. 
  Classical Sweet’s syndrome (CSS)[5] usually presents in 
women in the third and fourth decades of life and seen in 
association with various bacterial infections, connective 
tissue disorders, inflammatory bowel disease and pregnancy. 
The second type, the malignancy-associated Sweet’s 
syndrome (MASS)[5] occurs as a para-neoplastic syndrome. 
It may be the first presenting symptom of a hematologic or 
solid organ malignancy. MASS could be even be the marker 
of recurrence of malignancy. The third type of Sweet’s 
syndrome is drug-induced Sweet’s syndrome (DISS)[5], 
mostly seen in patients treated with granulocyte-colony 
stimulating factor. 
  The pathogenesis of Sweet’s syndrome remains to be 
established. It is postulated that the pathogenesis of Sweet’s 
syndrome may be multi-factorial. Clinical and laboratory 
evidences points to that of a cytokine mediated aetiology[4,5].  
  Systemic corticosteroid is the treatment of choice in Sweet’s 
syndrome. Other systemic drugs used are potassium iodide, 
colchicines, indomethacin, clofazimine, cyclosporine, and 
dapsone[5]. 
  There are many reports of leptospirosis presenting with 
neurological manifestations. These involvements are from 
the direct infection of nervous system such as aseptic 
meningitis, meningo-encephalitis and acute behavioural 
changes. The immune mediated manifestations include 
demyelination and polyneuritis[6]. Patients with vasculitis 
of the nervous system present as stroke with neurological 
deficits; such as and hemiparesis or monoparesis[7]. 
  The disease can be treated with doxycycline, penicillin, 
ceftrioxone or azithromycin based on the severity of the 
disease[8]. The disease can be prevented by administering 
doxycycline as prophylaxis in individuals at risk of exposure 
to contaminated water.
  In the review of literature, the association of Sweet’s 
syndrome as a manifestation of leptospirosis has not been 
described and possibly this is the only report on the same. 
To our knowledge this is the first report of leptospirosis 
presenting with Sweet’s syndrome and central nervous 
system vasculitis, its two uncommon manifestations.
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